Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin subunit beta 1 pseudogene 1 (ITGB1P1) is a processed pseudogene related to the integrin beta 1 gene family[1][5][7]. Pseudogenes are nonfunctional gene copies or gene fragments that generally do not code for proteins, though in some cases pseudogenes can have regulatory RNA functions at the transcript level[2]. ITGB1P1 does not encode an active integrin protein or contribute to integrin-mediated cell signaling or adhesion functions. Due to naming similarities, ITGB1P1 is often confused with ITGB1 (Integrin subunit beta 1), which is a genuine cell surface receptor involved in a variety of cellular processes[7]. Instead, ITGB1P1 is currently annotated as non-functional, with no direct therapeutic or biomarker use, and should not be considered a therapeutic target[1][5]. If you are seeking information on a druggable integrin (such as integrin beta 1), you should refer to “Integrin subunit beta 1” (ITGB1), not ITGB1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin subunit beta 1 pseudogene 1 (ITGB1P1).